Topical immunotherapy influence on citokins genes expression in skin and blood in atopicdermatitis patients
- Authors: Filimonova TM1, Elisyutina OG1, Fedenko ES1, Boldyreva MN1, Smirnov VS2
-
Affiliations:
- Institute of Immunology
- Medical and biological scientific and industrial complex «Cytomed»
- Issue: Vol 7, No 4 (2010)
- Pages: 40-45
- Section: Articles
- URL: https://journal-vniispk.ru/raj/article/view/121228
- DOI: https://doi.org/10.36691/RJA878
- ID: 121228
Cite item
Open Access
Access granted
Subscription Access
Abstract
Background. To study the clinical effectiveness of topical immune modulator cream thymogen 0,05% and its influence on some immunological parameters in the skin and blood of atopic dermatitis (AD) patients. Materials and methods. 40 people were included in the study, who were divided into main (AD patients, n=20) and a control group (healthy donors, n=20). All AD patients received topical treatment with cream thymogen 0,05% during 14 days. Patients applied cream to affected skin 2 times daily. Clinical efficacy of the treatment was assessed by changes of following parameters: investigated global assessment (IGA), subjective evaluation of the itch intensity and skin dryness . Samples of skin biopsies and peripheral blood of AD patients and healthy donors were tested for gene expression of cytokines by polymerase chain reaction in real time. Results. Topical treatment with cream thymogen 0,05% during 14 days in all AD patients showed positive clinical effect: reduction of dryness and itch. Immunological analysis revealed a significant increasing of cytokine IL-7 gene expression and decreasing of cytokines IL-8, IL-5 genes expression (p<0,05). In the peripheral blood no significant differences of cytokines genes expression before and after the treatment with cream thymogen 0,05% in comparison with healthy donors have been detected.
Conclusion. Cream thymogen 0,05% showed a local immunomodulating activity resulted in the decreasing of the intensity of skin inflammation and clinical improvement in AD patients. Changes of cytokines genes expression in skin, but not in blood were identified.
Conclusion. Cream thymogen 0,05% showed a local immunomodulating activity resulted in the decreasing of the intensity of skin inflammation and clinical improvement in AD patients. Changes of cytokines genes expression in skin, but not in blood were identified.
About the authors
T M Filimonova
Institute of ImmunologyInstitute of Immunology
O G Elisyutina
Institute of Immunology
Email: el-olga@yandex.ru
Institute of Immunology
E S Fedenko
Institute of ImmunologyInstitute of Immunology
M N Boldyreva
Institute of ImmunologyInstitute of Immunology
V S Smirnov
Medical and biological scientific and industrial complex «Cytomed»Medical and biological scientific and industrial complex «Cytomed»
References
- Российский национальный согласительный документ по атопическому дерматиту. Под ред. P.M. Хаитова, А.А. Кубановой. Атопический дерматит: рекомендации для практических врачей. М., «Фармарус Принт». 2002, 24 с.
- Hogan A.D., Burks A.W. Epidermal Langerhans cells and their function in the skin immune system. Ann. Allergy Asthma Immunol. 1995, v. 71 (1), p. 5-10.
- Hauser C. The interaction between Langerhans cells and CD4+ T-cell. J. Dermatol. 1992, v. 19 (11), p. 722-725.
- Robert C, Kupper T.S. Inflammatory skin diseases, T-cell, and immune surveillance. N. Engl. J. Med. 1999, v. 341, p. 1817-188.
- Agace W.W., Higgins J.M., Sadasivan B. et al. T-lymphocyte - epithelial cell interactions: integrin aEb7, LEEP-CAM and chemokines. Curr. Opin. Cell Biol. 2000, v. 12, p. 563-568.
- Кунгуров Н.В. Иммунологические аспекты атопического дерматита. Вестн. дерматол. 1999, № 6, с. 14-17.
- Elkord E. Role of regulatory T-cells in allergy: implications for therapeutic strategy. Inflamm. Allergy. Drug Targets. 2006, v. 5 (4), p. 211-217.
- Leung D. Pathogenesis of atopic dermatitis. J. Allergy Clin. Immunol. 1999, v. 104, p. 99-108.
- Reinhold U. et al. Cytokine release from cultured peripheral blood mononuclear cells of patients with severe atopic dermatitis. Acta Derm. Venereol (Stockh.). 1989, v. 69, p. 497-502.
- Leung D. Atopic dermatitis: the skin as a window into the pathogenesis of chronic allergic disease. J. All Clin. Immunol. 1995, v. 96, p. 312-319.
- Коmine M. Analysis of the mechanism for the development of allergic skin inflammation and the application for its 10. 10. treatment: keratinocytes in atopic dermatitis - their pathogenic involvement. J. Pharmacol Sci. 2009, v. 110 (3), p. 260-264.
- Weller RF. Role of eosinophils in allergy. Curr. Opin Immunol. 1999, v. 4, p. 782-787.
- Mudde G.C., Van Reijsen EC, Boland GJ. et al. Allergen presentation by epidermal Langerhans cells from patients with atopic dermatitis is mediated by IgE. Immunol. 1990, v. 69, p. 41, 335.
- Leung D. Pathogenesis of atopic dermatitis. J. Allergy Clin. Immunol. 1999, v. 104, p. 99-108.
- Leung Y.M., Soter N.A. Cellular and immunologic mechanisms in atopic dermatitis. J. Am. Acad. Dermatol. 2001, v. 44, p.1-12.
- Hogan A.D., Burks A.W. Epidermal Langerhans cells and their function in the skin immune system. Ann Allergy Asthma Immunol. 1995, v. 71 (1), p. 5-10.
- Akdis C.A. Review article Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology. American Academy of Allergy, Asthma and Immunology. PRACTALL Consensus report. Allergy. 2006, v. 61, p. 969-987.
- Морозов В.Е, Хавинсон В.Х., Малинин В.В. Пептидные тимомиметики. СПб., «Наука». 2000, с. 158.
- Hanifin J.M., Rajka G. Diagnostic features of atopic dermatitis. Acta Derm. Venerol. 1980, v. 92, p. 44-47.
Supplementary files
